{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:28:47Z","timestamp":1786663727177,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Intramural Cultivation Grant of the No.984 hospital of PLA","award":["20250605-10"],"award-info":[{"award-number":["20250605-10"]}]},{"name":"Joint Logistics Medical High-Quality Specialty Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Electroconvulsive therapy (ECT) is an established and effective treatment for patients with medication-resistant psychiatric disorders. However, the optimal choice of anesthetic agent for ECT induction remains a subject of ongoing debate. Remimazolam, a novel ultra-short-acting benzodiazepine, has yet to be systematically evaluated in the context of ECT anesthesia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a prospective, double-blind, randomized, crossover trial in hospitalized patients scheduled for ECT. Participants were randomly assigned to different treatment sequences, receiving either remimazolam (0.2\u00a0mg\/kg) or propofol (2\u00a0mg\/kg) for anesthesia induction in a crossover manner. The primary outcome was EEG seizure duration. Secondary outcomes included seizure adequacy endpoint, anesthesia-related parameters and safety profiles. All analyses were performed using generalized linear mixed-effects models, with treatment condition, stimulus dose, and treatment sequence as fixed effects and participant-specific random intercepts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 284 ECT sessions from 56 patients were included in the analysis. The remimazolam group demonstrated significantly longer EEG seizure duration (37.0\u00a0s vs. 18.5\u00a0s;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and EMG seizure duration (15.0\u00a0s vs. 9.0\u00a0s,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), higher average seizure energy index (24,767.4 \u00b5V\n                      <jats:sup>2<\/jats:sup>\n                      vs. 15,702.7 \u00b5V\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and greater maximum sustained power (38,197.7 \u00b5V\n                      <jats:sup>2<\/jats:sup>\n                      vs. 30,833.7 \u00b5V\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). However, remimazolam was associated with a higher incidence of post-ictal hypertension and tachycardia, as well as prolonged induction and recovery time.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Remimazolam is an effective anesthetic induction agent for ECT, offering superior seizure quality metrics compared to propofol. However, clinicians should remain vigilant regarding the potential for post-ictal cardiovascular hyperdynamic states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Chinese Clinical Trial Registry (number: ChiCTR2500114332; date: December 10, 2025).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-08202-x","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:14:37Z","timestamp":1779441277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seizure adequacy and safety of remimazolam in electroconvulsive therapy for patients with psychiatric disorders: a double-blind randomized crossover trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Tianqi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmiao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"8202_CR1","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137-150.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"8202_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12888-025-06932-y","volume":"25","author":"Y Fan","year":"2025","unstructured":"Fan Y, Fan A, Yang Z, Fan D. Global burden of mental disorders in 204 countries and territories, 1990\u20132021: Results from the global burden of disease study 2021. BMC Psychiatry. 2025;25:486. https:\/\/doi.org\/10.1186\/s12888-025-06932-y.","journal-title":"BMC Psychiatry"},{"key":"8202_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/35002776","volume":"403","author":"M Fink","year":"2000","unstructured":"Fink M. ECT has proved effective in treating depression. Nature. 2000;403:826. https:\/\/doi.org\/10.1038\/35002776.","journal-title":"Nature"},{"key":"8202_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5498\/wjp.v5.i2.182","volume":"5","author":"F Luchini","year":"2015","unstructured":"Luchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World J Psychiatry. 2015;5:182\u201392. https:\/\/doi.org\/10.5498\/wjp.v5.i2.182.","journal-title":"World J Psychiatry"},{"key":"8202_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","volume":"361","author":"UK ECT Review Group","year":"2003","unstructured":"UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet. 2003;361:799\u2013808. https:\/\/doi.org\/10.1016\/S0140-6736(03)12705-5.","journal-title":"Lancet"},{"key":"8202_CR6","doi-asserted-by":"publisher","first-page":"1251882","DOI":"10.3389\/fneur.2023.1251882","volume":"14","author":"SMM Akhtar","year":"2023","unstructured":"Akhtar SMM, Saleem SZ, Rizvi SHA, Raja S, Asghar MS. Beyond the surface: Analyzing etomidate and propofol as anesthetic agents in electroconvulsive therapy-a systematic review and meta-analysis of seizure duration outcomes. Front Neurol. 2023;14:1251882. https:\/\/doi.org\/10.3389\/fneur.2023.1251882.","journal-title":"Front Neurol"},{"key":"8202_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2147\/NDT.S467695","volume":"20","author":"X Dai","year":"2024","unstructured":"Dai X, Zhang R, Deng N, Tang L, Zhao B. Anesthetic influence on electroconvulsive therapy: A comprehensive review. Neuropsychiatr Dis Treat. 2024;20:1491\u2013502. https:\/\/doi.org\/10.2147\/NDT.S467695.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"8202_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12888-025-07105-7","volume":"25","author":"T Shen","year":"2025","unstructured":"Shen T, Yin X, Yu X, Song H, Li M, Li X, et al. The impact of hyperventilation on seizure duration following electroconvulsive therapy: A systematic review and meta-analysis of randomized trials. BMC Psychiatry. 2025;25:661. https:\/\/doi.org\/10.1186\/s12888-025-07105-7.","journal-title":"BMC Psychiatry"},{"key":"8202_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1021\/acsptsci.4c00745","volume":"8","author":"M Kazi","year":"2025","unstructured":"Kazi M, Gaskari A, Shahba AA, Ahmad S, Aldughaim MS, Hussain MD. Propofol: Current updates, challenges, and strategies for improved self-nanoemulsifying formulation. ACS Pharmacol Transl Sci. 2025;8:1013\u201327. https:\/\/doi.org\/10.1021\/acsptsci.4c00745.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"8202_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/YCT.0b013e31825957b1","volume":"28","author":"Y Tang","year":"2012","unstructured":"Tang Y, Jiang W, Ren Y, Ma X, Cotes RO, McDonald WM. Electroconvulsive therapy in China: Clinical practice and research on efficacy. J ECT. 2012;28:206\u201312. https:\/\/doi.org\/10.1097\/YCT.0b013e31825957b1.","journal-title":"J ECT"},{"key":"8202_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/YCT.0b013e3182617ef9","volume":"28","author":"Y Ren","year":"2012","unstructured":"Ren Y, Jiang W, Cotes RO, Tang Y, Ma X, McDonald WM. Electroconvulsive therapy in China (II): Research on the technical parameters and mechanism of action. J ECT. 2012;28:213\u20138. https:\/\/doi.org\/10.1097\/YCT.0b013e3182617ef9.","journal-title":"J ECT"},{"key":"8202_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/2045-9912.350860","volume":"13","author":"H Modir","year":"2023","unstructured":"Modir H, Mahmoodiyeh B, Shayganfard M, Abdus A, Almasi-Hashiani A. Efficacy of ketamine, propofol, and dexmedetomidine for anesthesia in electroconvulsive therapy in treatment-resistant major depressive disorder patients: a double-blind randomized clinical trial. Med Gas Res. 2023;13:112\u20137. https:\/\/doi.org\/10.4103\/2045-9912.350860.","journal-title":"Med Gas Res"},{"key":"8202_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/ACO.0000000000001279","volume":"36","author":"T Ninke","year":"2023","unstructured":"Ninke T, Groene P. Electroconvulsive therapy: Recent advances and anesthetic considerations. Curr Opin Anaesthesiol. 2023;36:441\u20136. https:\/\/doi.org\/10.1097\/ACO.0000000000001279.","journal-title":"Curr Opin Anaesthesiol"},{"key":"8202_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/ACO.0000000000000624","volume":"31","author":"M Soehle","year":"2018","unstructured":"Soehle M, Bochem J. Anesthesia for electroconvulsive therapy. Curr Opin Anaesthesiol. 2018;31:501\u20135. https:\/\/doi.org\/10.1097\/ACO.0000000000000624.","journal-title":"Curr Opin Anaesthesiol"},{"key":"8202_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_491_22","volume":"65","author":"J Thirthalli","year":"2023","unstructured":"Thirthalli J, Sinha P, Sreeraj VS. Clinical practice guidelines for the use of electroconvulsive therapy. Indian J Psychiatry. 2023;65:258\u201369. https:\/\/doi.org\/10.4103\/indianjpsychiatry.indianjpsychiatry_491_22.","journal-title":"Indian J Psychiatry"},{"key":"8202_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12871-024-02422-y","volume":"24","author":"X An","year":"2024","unstructured":"An X, Shen T, Yin X, Xu J, Zhang Y, Wang T. The safety of remimazolam versus propofol in gastroscopic sedation: A meta-analysis. BMC Anesthesiol. 2024;24:40. https:\/\/doi.org\/10.1186\/s12871-024-02422-y.","journal-title":"BMC Anesthesiol"},{"key":"8202_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-025-09755-9","volume":"649","author":"C Yue","year":"2026","unstructured":"Yue C, Wang N, Zhai H, Yuan Z, Cui Y, Quan J, et al. Adenosine signalling drives antidepressant actions of ketamine and ECT. Nature. 2026;649:423\u201331. https:\/\/doi.org\/10.1038\/s41586-025-09755-9.","journal-title":"Nature"},{"key":"8202_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41380-023-02366-8","volume":"29","author":"TG Rhee","year":"2024","unstructured":"Rhee TG, Shim SR, Popp JH, Trikalinos TA, Rosenheck RA, Kellner CH, et al. Efficacy and safety of ketamine-assisted electroconvulsive therapy in major depressive episode: A systematic review and network meta-analysis. Mol Psychiatry. 2024;29:750\u20139. https:\/\/doi.org\/10.1038\/s41380-023-02366-8.","journal-title":"Mol Psychiatry"},{"key":"8202_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI, Ketamine. A review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55:1059\u201377. https:\/\/doi.org\/10.1007\/s40262-016-0383-6.","journal-title":"Clin Pharmacokinet"},{"key":"8202_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/10600280241260754","volume":"59","author":"DJ Sicignano","year":"2025","unstructured":"Sicignano DJ, Kantesaria R, Mastropietro M, Sedensky A, Kohlbrecher R, Hernandez AV, et al. The impact of ketamine-based versus non-ketamine-based ECT anesthesia regimens on the severity of patients\u2019 depression and occurrence of adverse events: A systematic review with meta-analysis. Ann Pharmacother. 2025;59:250\u201361. https:\/\/doi.org\/10.1177\/10600280241260754.","journal-title":"Ann Pharmacother"},{"key":"8202_CR21","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2147\/NDT.S157233","volume":"14","author":"V Jankauskas","year":"2018","unstructured":"Jankauskas V, Necyk C, Chue J, Chue P. A review of ketamine\u2019s role in ECT and non-ECT settings. Neuropsychiatr Dis Treat. 2018;14:1437\u201350. https:\/\/doi.org\/10.2147\/NDT.S157233.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"8202_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jad.2023.02.085","volume":"330","author":"V Millischer","year":"2023","unstructured":"Millischer V, Pramhas S, Wiedermann I, Eder V, Kress HG, Michalek-Sauberer A, et al. Comparison of etomidate and methohexital as anesthetic agents for continuation and maintenance electroconvulsive therapy: A retrospective analysis of seizure quality and safety. J Affect Disord. 2023;330:33\u20139. https:\/\/doi.org\/10.1016\/j.jad.2023.02.085.","journal-title":"J Affect Disord"},{"key":"8202_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/YCT.0b013e3182182be0","volume":"27","author":"N Wang","year":"2011","unstructured":"Wang N, Wang XH, Lu J, Zhang JY. The effect of repeated etomidate anesthesia on adrenocortical function during a course of electroconvulsive therapy. J ECT. 2011;27:281\u20135. https:\/\/doi.org\/10.1097\/YCT.0b013e3182182be0.","journal-title":"J ECT"},{"key":"8202_CR24","doi-asserted-by":"publisher","unstructured":"Hughes RL. More on etomidate and ECT. Anaesthesia. 2006;61:407. https:\/\/doi.org\/10.1111\/j.1365-2044.2006.04597.x.","DOI":"10.1111\/j.1365-2044.2006.04597.x"},{"key":"8202_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s40265-021-01544-8","volume":"81","author":"A Lee","year":"2021","unstructured":"Lee A, Shirley M, Remimazolam. A review in procedural sedation. Drugs. 2021;81:1193\u2013201. https:\/\/doi.org\/10.1007\/s40265-021-01544-8.","journal-title":"Drugs"},{"key":"8202_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12871-025-03117-8","volume":"25","author":"P Luo","year":"2025","unstructured":"Luo P, Wu J, Lan H, Xu Q, Duan G. Safety of remimazolam in deep sedation during flexible fiberoptic bronchoscopy: A prospective, randomized controlled trial. BMC Anesthesiol. 2025;25:246. https:\/\/doi.org\/10.1186\/s12871-025-03117-8.","journal-title":"BMC Anesthesiol"},{"key":"8202_CR27","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.2147\/DDDT.S384155","volume":"16","author":"Q Hu","year":"2022","unstructured":"Hu Q, Liu X, Wen C, Li D, Lei X, Remimazolam. An updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022;16:3957\u201374. https:\/\/doi.org\/10.2147\/DDDT.S384155.","journal-title":"Drug Des Devel Ther"},{"key":"8202_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/EJA.0000000000002126","volume":"42","author":"L Pingel","year":"2025","unstructured":"Pingel L, Maagaard M, Tvarn\u00f8 CD, Sorenson S, Bukhari S, Andersen LPK, et al. Remimazolam for procedural sedation: A systematic review with meta-analyses and trial sequential analyses. Eur J Anaesthesiol. 2025;42:298\u2013312. https:\/\/doi.org\/10.1097\/EJA.0000000000002126.","journal-title":"Eur J Anaesthesiol"},{"key":"8202_CR29","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.2147\/DDDT.S425590","volume":"17","author":"J Chen","year":"2023","unstructured":"Chen J, Zou X, Hu B, Yang Y, Wang F, Zhou Q, et al. Remimazolam vs etomidate: Haemodynamic effects in hypertensive elderly patients undergoing non-cardiac surgery. Drug Des Devel Ther. 2023;17:2943\u201353. https:\/\/doi.org\/10.2147\/DDDT.S425590.","journal-title":"Drug Des Devel Ther"},{"key":"8202_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.brs.2014.12.012","volume":"8","author":"V G\u00e1lvez","year":"2015","unstructured":"G\u00e1lvez V, Hadzi-Pavlovic D, Smith D, Loo CK. Predictors of seizure threshold in right unilateral ultrabrief electroconvulsive therapy: Role of concomitant medications and anaesthesia used. Brain Stimul. 2015;8:486\u201392. https:\/\/doi.org\/10.1016\/j.brs.2014.12.012.","journal-title":"Brain Stimul"},{"key":"8202_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40263-020-00729-1","volume":"34","author":"AU Janjua","year":"2020","unstructured":"Janjua AU, Dhingra AL, Greenberg R, McDonald WM. The efficacy and safety of concomitant psychotropic medication and electroconvulsive therapy (ECT). CNS Drugs. 2020;34:509\u201320. https:\/\/doi.org\/10.1007\/s40263-020-00729-1.","journal-title":"CNS Drugs"},{"key":"8202_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/YCT.0000000000001025","volume":"40","author":"I Park","year":"2024","unstructured":"Park I, Kim HG, Do S-H, Hwang JW, Yoon I-Y, Hong JK, et al. The effect of remimazolam on seizure profile, hemodynamics, and recovery in patients with electroconvulsive therapy comparison with propofol and etomidate: A retrospective study. J ECT. 2024;40:262\u20137. https:\/\/doi.org\/10.1097\/YCT.0000000000001025.","journal-title":"J ECT"},{"key":"8202_CR33","doi-asserted-by":"publisher","first-page":"e081123","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan A-W, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 statement: Updated guideline for reporting randomised trials. BMJ. 2025;389:e081123. https:\/\/doi.org\/10.1136\/bmj-2024-081123.","journal-title":"BMJ"},{"key":"8202_CR34","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.2147\/DDDT.S483029","volume":"18","author":"X-L Wang","year":"2024","unstructured":"Wang X-L, Dai L-L, Li Y-N, Zhang J-W, Qu M-C, Zhou Y-Y, et al. Comparing remimazolam and propofol for postoperative anesthesia satisfaction in outpatient gynecological surgery: A randomized clinical trial. Drug Des Devel Ther. 2024;18:4615\u201327. https:\/\/doi.org\/10.2147\/DDDT.S483029.","journal-title":"Drug Des Devel Ther"},{"key":"8202_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12877-025-05984-9","volume":"25","author":"B Chai","year":"2025","unstructured":"Chai B, Guo J, Xu Z, Chen T, Wang H, Zhu Z, et al. Comparison of the efficacy and safety of remimazolam and propofol for fiberoptic bronchoscopy in older patients: A prospective, randomized controlled study. BMC Geriatr. 2025;25:337. https:\/\/doi.org\/10.1186\/s12877-025-05984-9.","journal-title":"BMC Geriatr"},{"key":"8202_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s40001-025-02519-1","volume":"30","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhan R, Mo L, Zhang J, Hu J, Tan S, et al. Comparison of effect of remimazolam and propofol on respiration of patients under deep sedation for colonoscopy: A prospective multicenter randomized controlled trial. Eur J Med Res. 2025;30:250. https:\/\/doi.org\/10.1186\/s40001-025-02519-1.","journal-title":"Eur J Med Res"},{"key":"8202_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jad.2024.09.038","volume":"368","author":"Q-B Zeng","year":"2025","unstructured":"Zeng Q-B, Zou D-C, Huang X-B, Shang D-W, Huang X, Yang X-H, et al. Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial. J Affect Disord. 2025;368:320\u20138. https:\/\/doi.org\/10.1016\/j.jad.2024.09.038.","journal-title":"J Affect Disord"},{"key":"8202_CR38","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0193-953X(18)30271-5","volume":"14","author":"HA Sackeim","year":"1991","unstructured":"Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am. 1991;14:803\u201343.","journal-title":"Psychiatr Clin North Am"},{"key":"8202_CR39","doi-asserted-by":"publisher","first-page":"CD000076","DOI":"10.1002\/14651858.CD000076.pub2","volume":"2005","author":"P Tharyan","year":"2005","unstructured":"Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005;2005:CD000076. https:\/\/doi.org\/10.1002\/14651858.CD000076.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"8202_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155:137\u201346. https:\/\/doi.org\/10.1016\/j.chest.2018.09.015.","journal-title":"Chest"},{"key":"8202_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12871-025-03108-9","volume":"25","author":"S Zhou","year":"2025","unstructured":"Zhou S, Yu S, Bi Y, Tian Z, Pan R, Yan T, et al. The safety and efficacy of remimazolam, ciprofol, and propofol anesthesia in endoscopy: A systematic review and network meta-analysis. BMC Anesthesiol. 2025;25:230. https:\/\/doi.org\/10.1186\/s12871-025-03108-9.","journal-title":"BMC Anesthesiol"},{"key":"8202_CR42","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40265-020-01299-8","volume":"80","author":"SJ Keam","year":"2020","unstructured":"Keam SJ, Remimazolam. First approval. Drugs. 2020;80:625\u201333. https:\/\/doi.org\/10.1007\/s40265-020-01299-8.","journal-title":"Drugs"},{"key":"8202_CR43","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12325-024-02820-1","volume":"41","author":"L Huang","year":"2024","unstructured":"Huang L, Liu H, Zou X, Ding J, Tao S. Adverse drug events observed with the newly approved remimazolam in comparison to propofol for general anesthesia in patients undergoing surgery: A meta-analysis. Adv Ther. 2024;41:1896\u2013910. https:\/\/doi.org\/10.1007\/s12325-024-02820-1.","journal-title":"Adv Ther"},{"key":"8202_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4097\/kja.22297","volume":"75","author":"S-H Kim","year":"2022","unstructured":"Kim S-H, Fechner J. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent. Korean J Anesthesiol. 2022;75:307\u201315. https:\/\/doi.org\/10.4097\/kja.22297.","journal-title":"Korean J Anesthesiol"},{"key":"8202_CR45","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s40262-025-01548-7","volume":"64","author":"BT de Jong","year":"2025","unstructured":"de Jong BT, Eleveld DJ, Mason KP, Struys MMRF. Clinical pharmacokinetics and pharmacodynamics of remimazolam. Clin Pharmacokinet. 2025;64:1263\u201382. https:\/\/doi.org\/10.1007\/s40262-025-01548-7.","journal-title":"Clin Pharmacokinet"},{"key":"8202_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40263-024-01128-6","volume":"39","author":"AB Philip","year":"2025","unstructured":"Philip AB, Brohan J, Goudra B. The role of GABA receptors in anesthesia and sedation: An updated review. CNS Drugs. 2025;39:39\u201354. https:\/\/doi.org\/10.1007\/s40263-024-01128-6.","journal-title":"CNS Drugs"},{"key":"8202_CR47","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","volume":"39","author":"E Sigel","year":"2018","unstructured":"Sigel E, Ernst M. The benzodiazepine binding sites of GABAA receptors. Trends Pharmacol Sci. 2018;39:659\u201371. https:\/\/doi.org\/10.1016\/j.tips.2018.03.006.","journal-title":"Trends Pharmacol Sci"},{"key":"8202_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.036","author":"RW Olsen","year":"2018","unstructured":"Olsen RW. GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology. 2018;10\u201322. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.036. 136 Pt A."},{"key":"8202_CR49","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2654-5","volume":"585","author":"JJ Kim","year":"2020","unstructured":"Kim JJ, Gharpure A, Teng J, Zhuang Y, Howard RJ, Zhu S, et al. Shared structural mechanisms of general anaesthetics and benzodiazepines. Nature. 2020;585:303\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2654-5.","journal-title":"Nature"},{"key":"8202_CR50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamaneurol.2024.0108","volume":"81","author":"YK Au","year":"2024","unstructured":"Au YK, Kananeh MF, Rahangdale R, Moore TE, Panza GA, Gaspard N, et al. Treatment of refractory status epilepticus with continuous intravenous anesthetic drugs: A systematic review. JAMA Neurol. 2024;81:534\u201348. https:\/\/doi.org\/10.1001\/jamaneurol.2024.0108.","journal-title":"JAMA Neurol"},{"key":"8202_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ajem.2025.09.019","volume":"99","author":"J Pelletier","year":"2026","unstructured":"Pelletier J, Merriman W, Koyfman A, Long B. Benzodiazepine-refractory status epilepticus: A narrative review. Am J Emerg Med. 2026;99:62\u20139. https:\/\/doi.org\/10.1016\/j.ajem.2025.09.019.","journal-title":"Am J Emerg Med"},{"key":"8202_CR52","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/jnnp.64.6.802","volume":"64","author":"A Viguera","year":"1998","unstructured":"Viguera A, Rordorf G, Schouten R, Welch C, Drop LJ. Intracranial haemodynamics during attenuated responses to electroconvulsive therapy in the presence of an intracerebral aneurysm. J Neurol Neurosurg Psychiatry. 1998;64:802\u20135. https:\/\/doi.org\/10.1136\/jnnp.64.6.802.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8202_CR53","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12888-021-03406-9","volume":"21","author":"P Subsoontorn","year":"2021","unstructured":"Subsoontorn P, Lekprasert V, Waleeprakhon P, Ittasakul P, Laopuangsak A, Limpoon S. Premedication with dexmedetomidine for prevention of hyperdynamic response after electroconvulsive therapy: A cross-over, randomized controlled trial. BMC Psychiatry. 2021;21:408. https:\/\/doi.org\/10.1186\/s12888-021-03406-9.","journal-title":"BMC Psychiatry"},{"key":"8202_CR54","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00702-021-02420-1","volume":"128","author":"C Pollak","year":"2021","unstructured":"Pollak C, Maier HB, Moschny N, Jahn K, Bleich S, Frieling H, et al. Epinephrine levels decrease in responders after electroconvulsive therapy. J Neural Transm (Vienna). 2021;128:1917\u201321. https:\/\/doi.org\/10.1007\/s00702-021-02420-1.","journal-title":"J Neural Transm (Vienna)"},{"key":"8202_CR55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12871-023-02135-8","volume":"23","author":"H Chen","year":"2023","unstructured":"Chen H, Ding X, Xiang G, Xu L, Liu Q, Fu Q, et al. Analysis of the efficacy of subclinical doses of esketamine in combination with propofol in non-intubated general anesthesia procedures - a systematic review and meta-analysis. BMC Anesthesiol. 2023;23:245. https:\/\/doi.org\/10.1186\/s12871-023-02135-8.","journal-title":"BMC Anesthesiol"},{"key":"8202_CR56","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.2147\/DDDT.S474275","volume":"18","author":"L Lu","year":"2024","unstructured":"Lu L, Chen B, Zhao X, Zhai J, Zhang P, Hua Z. Comparison of remimazolam and propofol in recovery of elderly outpatients undergoing gastrointestinal endoscopy: A randomized, non-inferiority trial. Drug Des Devel Ther. 2024;18:4307\u201318. https:\/\/doi.org\/10.2147\/DDDT.S474275.","journal-title":"Drug Des Devel Ther"},{"key":"8202_CR57","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12871-024-02746-9","volume":"24","author":"H Tan","year":"2024","unstructured":"Tan H, Lou A, Wu J, Chen X, Qian X. Comparison of hypotension between propofol and remimazolam-propofol combinations sedation for day-surgery hysteroscopy: A prospective, randomized, controlled trial. BMC Anesthesiol. 2024;24:360. https:\/\/doi.org\/10.1186\/s12871-024-02746-9.","journal-title":"BMC Anesthesiol"},{"key":"8202_CR58","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.brs.2010.12.004","volume":"4","author":"Y Levkovitz","year":"2011","unstructured":"Levkovitz Y, Sheer A, Harel EV, Katz LN, Most D, Zangen A, et al. Differential effects of deep TMS of the prefrontal cortex on apathy and depression. Brain Stimul. 2011;4:266\u201374. https:\/\/doi.org\/10.1016\/j.brs.2010.12.004.","journal-title":"Brain Stimul"},{"key":"8202_CR59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12871-022-01713-6","volume":"22","author":"J Guo","year":"2022","unstructured":"Guo J, Qian Y, Zhang X, Han S, Shi Q, Xu J. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: A prospective, randomized and controlled study. BMC Anesthesiol. 2022;22:180. https:\/\/doi.org\/10.1186\/s12871-022-01713-6.","journal-title":"BMC Anesthesiol"},{"key":"8202_CR60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12871-023-02092-2","volume":"23","author":"W Luo","year":"2023","unstructured":"Luo W, Sun M, Wan J, Zhang Z, Huang J, Zhang J, et al. Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: A prospective randomized controlled trial. BMC Anesthesiol. 2023;23:182. https:\/\/doi.org\/10.1186\/s12871-023-02092-2.","journal-title":"BMC Anesthesiol"},{"key":"8202_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000524400","volume":"91","author":"SL Dubovsky","year":"2022","unstructured":"Dubovsky SL, Marshall D. Benzodiazepines remain important therapeutic options in psychiatric practice. Psychother Psychosom. 2022;91:307\u201334. https:\/\/doi.org\/10.1159\/000524400.","journal-title":"Psychother Psychosom"},{"key":"8202_CR62","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/bja\/81.3.422","volume":"81","author":"S Dutta","year":"1998","unstructured":"Dutta S, Matsumoto Y, Muramatsu A, Matsumoto M, Fukuoka M, Ebling WF. Steady-state propofol brain:Plasma and brain:blood partition coefficients and the effect-site equilibration paradox. Br J Anaesth. 1998;81:422\u20134. https:\/\/doi.org\/10.1093\/bja\/81.3.422.","journal-title":"Br J Anaesth"},{"key":"8202_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4266\/acc.2022.00619","volume":"37","author":"H-R Choi","year":"2022","unstructured":"Choi H-R, Song I-A. Review of remimazolam and sedatives in the intensive care unit. Acute Crit Care. 2022;37:151\u20138. https:\/\/doi.org\/10.4266\/acc.2022.00619.","journal-title":"Acute Crit Care"},{"key":"8202_CR64","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.bja.2023.08.019","volume":"131","author":"Y-Q Gao","year":"2023","unstructured":"Gao Y-Q, Ihmsen H, Hu Z-Y, Sun W, Fang Y-B, Wang Z, et al. Pharmacokinetics of remimazolam after intravenous infusion in anaesthetised children. Br J Anaesth. 2023;131:914\u201320. https:\/\/doi.org\/10.1016\/j.bja.2023.08.019.","journal-title":"Br J Anaesth"},{"key":"8202_CR65","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","volume":"132","author":"J Sch\u00fcttler","year":"2020","unstructured":"Sch\u00fcttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132:636\u201351. https:\/\/doi.org\/10.1097\/ALN.0000000000003103.","journal-title":"Anesthesiology"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08202-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08202-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08202-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:08:48Z","timestamp":1786662528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08202-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8202"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08202-x","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.neuropharm.2018.01.036","asserted-by":"subject"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki, approved by the Ethics Committee of the No.984 Hospital of PLA (approval number: 2025060513; date: June 5, 2025) and registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2500114332; date: December 10, 2025). Consent was obtained from legally authorized representatives.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"625"}}